Last edition
News about "B7H3"
MediLink, Roche Sign Global Licensing Deal for YL201 ADC Therapy
Agreement includes USD 570 million upfront and milestones to advance B7H3-targeting solid tumor cancer treatment worldwide.
B7H3 | 09/01/2026 | By News Bureau | 201
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members